Free Trial

Moelis & Company (NYSE:MC) PT Raised to $60.00 at UBS Group

Moelis & Company logo with Finance background

Moelis & Company (NYSE:MC - Get Free Report) had its price objective boosted by stock analysts at UBS Group from $54.00 to $60.00 in a research note issued on Tuesday, Benzinga reports. The brokerage currently has a "sell" rating on the asset manager's stock. UBS Group's price objective indicates a potential downside of 10.89% from the company's current price.

Several other brokerages have also weighed in on MC. JPMorgan Chase & Co. boosted their price objective on Moelis & Company from $50.00 to $51.00 and gave the company a "neutral" rating in a report on Thursday, July 25th. Keefe, Bruyette & Woods reaffirmed a "market perform" rating and issued a $60.00 price objective (up previously from $54.00) on shares of Moelis & Company in a report on Thursday, July 25th. Wells Fargo & Company assumed coverage on shares of Moelis & Company in a research note on Thursday, September 12th. They set an "equal weight" rating and a $70.00 target price for the company. Finally, Morgan Stanley lifted their price target on shares of Moelis & Company from $61.00 to $67.00 and gave the company an "underweight" rating in a report on Monday, September 23rd. Two equities research analysts have rated the stock with a sell rating and six have issued a hold rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $61.00.

View Our Latest Stock Report on MC

Moelis & Company Stock Up 1.1 %

Shares of MC traded up $0.73 during trading on Tuesday, reaching $67.33. The company's stock had a trading volume of 133,787 shares, compared to its average volume of 627,307. The company has a market cap of $5.04 billion, a price-to-earnings ratio of -354.37 and a beta of 1.33. The company has a fifty day moving average of $65.76 and a two-hundred day moving average of $59.47. Moelis & Company has a twelve month low of $38.58 and a twelve month high of $71.34.

Moelis & Company (NYSE:MC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 24th. The asset manager reported $0.18 EPS for the quarter, beating analysts' consensus estimates of $0.11 by $0.07. The firm had revenue of $264.59 million for the quarter, compared to the consensus estimate of $227.90 million. Moelis & Company had a net margin of 1.38% and a return on equity of 4.38%. The firm's revenue was up 47.1% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.04) EPS. As a group, equities analysts forecast that Moelis & Company will post 1.08 EPS for the current fiscal year.

Insider Activity at Moelis & Company

In related news, CEO Kenneth Moelis sold 5,308 shares of the business's stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $68.87, for a total transaction of $365,561.96. Following the transaction, the chief executive officer now owns 86 shares of the company's stock, valued at approximately $5,922.82. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, CFO Joseph Simon sold 6,723 shares of the business's stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $64.00, for a total transaction of $430,272.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Kenneth Moelis sold 5,308 shares of the business's stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $68.87, for a total value of $365,561.96. Following the sale, the chief executive officer now directly owns 86 shares of the company's stock, valued at $5,922.82. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 12,526 shares of company stock valued at $830,133. Corporate insiders own 6.40% of the company's stock.

Institutional Investors Weigh In On Moelis & Company

Institutional investors have recently made changes to their positions in the stock. SkyView Investment Advisors LLC grew its position in shares of Moelis & Company by 1.4% during the 2nd quarter. SkyView Investment Advisors LLC now owns 13,866 shares of the asset manager's stock worth $788,000 after buying an additional 188 shares during the period. Bank of Montreal Can grew its holdings in Moelis & Company by 2.7% during the second quarter. Bank of Montreal Can now owns 7,181 shares of the asset manager's stock valued at $409,000 after purchasing an additional 192 shares during the period. UMB Bank n.a. increased its stake in Moelis & Company by 63.5% in the second quarter. UMB Bank n.a. now owns 497 shares of the asset manager's stock valued at $28,000 after purchasing an additional 193 shares in the last quarter. Vanguard Personalized Indexing Management LLC raised its holdings in Moelis & Company by 3.1% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 6,390 shares of the asset manager's stock worth $363,000 after purchasing an additional 193 shares during the period. Finally, Peak Financial Advisors LLC grew its holdings in shares of Moelis & Company by 2.9% in the 1st quarter. Peak Financial Advisors LLC now owns 8,715 shares of the asset manager's stock valued at $495,000 after buying an additional 245 shares during the period. 91.53% of the stock is owned by institutional investors and hedge funds.

About Moelis & Company

(Get Free Report)

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.

Recommended Stories

Analyst Recommendations for Moelis & Company (NYSE:MC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ U.S. Stock Market Now on Verge of Collapse (From Stansberry Research) (Ad)

Should you invest $1,000 in Moelis & Company right now?

Before you consider Moelis & Company, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Moelis & Company wasn't on the list.

While Moelis & Company currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Star Bulk Carriers Stock 28% Upside: Can This Small Cap Deliver?
These 3 Small-Cap Stocks Could be the Hidden Gems of 2025
Broadcom’s Momentum Returns: Will It Reach New Highs?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines